3rd Quarter - Report

AMERICAN THORACIC SOCIETY for AMERICAN THORACIC SOCIETY

Firm
Client
Income
—
Expenses
$144,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID supplemental legislation Fy2021 Labor-HHS appropriations - NIH, CDC, HRSA funding and policy

LobbyistCovered position, as disclosed
NUALA MOORE —

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

FY21 Agriculture Appropriation bill S.9 Traditional Cigar Manufacture and Jobs Preservation Act

LobbyistCovered position, as disclosed
GARY WARREN EWART Director, ATS Government Relations
NUALA MOORE Senior Legislative Representative

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: S. 9 (116th)

Veterans VET

FY 21 Mil/Con/VA Appropriations bill - VA research funding

LobbyistCovered position, as disclosed
GARY WARREN EWART —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Environmental Protection Agency (EPA)

Foreign Relations FOR

FY2021 State-Foreign Operations appropriations

LobbyistCovered position, as disclosed
NUALA MOORE Senior Legislative Representative

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Clean Air and Water (quality) CAW

FY2021 Interior-Environment appropriations - EPA funding and Clean Air Policy

LobbyistCovered position, as disclosed
GARY WARREN EWART Director, ATS Government Relations

Contacted: Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.